SOME PROBLEMS OF ARTERIAL HYPERTENSION PHARMACOTHERAPY: IMPLEMENTATION OF MEDICAL RECOMMENDATIONS AND CHOICE OF MEDICINE

1. OdutayoA, WongCX, HsiaoAJ, etal. Atrial fbrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482 10.1136/bmj.i4482

2. Mente A, O’Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016;388:465–75. 10.1016/S0140- 6736(16)30467-6

3. Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular fltration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015;3:514–25. 10.1016/ S2213-8587(15)00040-6

4. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–44. 10.2337/diacare.16.2.434

5.Kayumov U.K., Kalandarova U.A., Ibadova M.U., Ismatova M.N.The formation of a hard «end points» for various risk factors. Journal of Biomedicine and Practice, 2019, vol. 1, issue 1, pp.80–85. https://www.tadqiqot.uz/wp-content/uploads/2019/05/ biomedicine-2019-1/biomedicine-2019-01.pdf http://dx.doi.org/10.26739/2181-9297-2019-1-14.

6. Hao Wang, Ying Ba, Run-Ce Cai, and Qian Xing. Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies. BMJ Open. 2019; 9(7): e024935. Published online 2019 Jul 17. doi: 10.1136/bmjopen-2018-024935. https://europepmc.org/articles/ pmc6661591#fragment-fulltext

7. Каюмов У.К. Изучение некоторых внутренних болезней при метаболическом синдроме и различных категориях гипергликемии. Евразийский научный журнал. 2017. -№2. – С. 405-408. https://elibrary.ru/item.asp?id=28872542

8. Абдухакимова Н.А., Хатамова Д.Т., Каюмов У.К. Частота и уровни некоторых основных компонентов метаболического синдрома у больных подагрой при сахарном диабете и нарушенной толерантности к глюкозе. Врачаспирант. - 2009. - №3. – С. 182-183. http://www.wisesoft.ru/load4317.htm

9. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., E. Grobbee D., Jaarsma T., Kirchhof P., E. Kjeldsen S., Laurent S., J. Manolis A., M. Nilsson P., Miguel Ruilope L., E. Schmieder R., Sirnes P., Sleight P., Viigimaa M., Waeber B., Zannad F. 2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2014;(1):7-94. https://doi. org/10.15829/1560-4071-2014-1-7-94.